COVID-19 Statement

Chairs

Leontien Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Melissa Hudson, Department of 1) Oncology and 2) Epidemiology and Cancer Control,St. Jude Children’s Research Hospital, Memphis, United States

Coordinators

Lisanne Verbruggen, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Yuehan Wang, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Advisors

Saro Armenian, City of Hope National Medical Center, Duarte, CA, United States
Matthew Ehrhardt, Department of 1) Oncology and 2) Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, TN, Memphis, United States
Roderick Skinner, Department of Paediatric and Adolescent Haematology/Oncology, Great North Children’s Hospital, and Clinical and Translational Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom
Claudia Kuehni, Swiss Childhood Cancer Registry, Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland
Renée Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Elvira van Dalen, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Helena van der Pal, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

WG members

Jorrit van As, c/o Cochrane Childhood Cancer, The Netherlands
Edit Bardi, St Anna Childrens Hospital, Vienna, Austria and Kepler Universitätsklinikum, Linz, Austria and Semmelweis University, Budapest, Hungary
Katja Baust, Department for Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany
Claire Berger, Department for Pediatric Hematology and Oncology CHU Nord,University Hospital Saint-Etienne, Saint-Priest en Jarez France and Epidemiology of Childhood and Adolescent Cancers, Paris Descartes University, Villejuif, France
Elio Castagnola, Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
Katie Devine, Rutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, NJ, United States
Judith Gebauer, Institute for Endocrinology and Diabetes, University of Luebeck, Luebeck, Germany
Jordan Gilleland Marchak, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, GA, United States
Adam Glaser, Department of Paediatric Oncology, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom
Andreas Groll, Infectious Disease Research Program Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology University Children’s Hospital Münster, Germany
Gabrielle Haeusler, NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; and Departments of Infectious Diseases, Peter MacCallum Cancer Centre and Royal Children’s Hospital, Parkville, Victoria, Australia; and Murdoch Children’s Research Institute, Parkville, Victoria, Australia
Jaap den Hartogh, Dutch Childhood Cancer Parent Organization VOKK Netherlands, Department VOX Survivors, Nieuwegein, The Netherlands
Riccardo Haupt, Epidemiology and Biostatistics Unit and DOPO clinic IRCCS Istituto Giannina Gaslini, Genova, Italy
Lars Hjorth, Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Pediatrics, Lund, Sweden
Miho Kato, Dept of Pediatric Hematology/Oncology, Okinawa Prefectural Nanbu Medical Center & Children’s Medical Center, Okinawa, Japan
Tomáš Kepák, University Hospital Brno and St. Anna University Hospital/ICRC, Masaryk University, Brno, Czech republic
Maria (Rianne) Koopman, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Thorsten Langer, University Hospital for Children and Adolescents, Pediatric Oncology and Hematology, Luebeck, Germany
Miho Maeda, Department of Pediatrics, Nippon Medical School, Tokyo, Japan
Gisela Michel, Dept Heatlh Sciences and Medicine, University of Lucerne, Switzerland
Monica Muraca, Epidemiology and Biostatistics Unit and DOPO clinic IRCCS Istituto Giannina Gaslini, Genova, Italy
Paul Nathan, The Hospital for Sick Children, Toronto, Canada
Selina van den Oever, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Vesna Pavasovic, Department of Malignant Haematology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom
Satomi Sato, St. Luke’s International University, Tokyo, Japan
Fiona Schulte, Department of Oncology, Division of Psychosocial Oncology, University of Calgary, Calgary, AB, Canada
Lillian Sung, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada
Wim Tissing, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands, and department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Anne Uyttebroeck, Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium